S&P 500NASDAQ-100

Gilead Sciences (GILD) — 10-Year DCF Projection Model

Free stock research tool. Build a 10-year revenue, earnings (EPS), and free cash flow forecast for Gilead Sciences (GILD) stock, a company in the Health Care (Biotechnology) sector. Pulls audited SEC EDGAR XBRL financials, triangulates Wall Street analyst consensus across Yahoo Finance, NASDAQ, and StockAnalysis, and overlays AI-clustered news + social event probabilities directly onto projected EPS. For equity research — not personal budgeting or accounting.

Build GILD projection model →Browse all stocks

Gilead Sciences at a glance

Ticker
GILD
Company
Gilead Sciences
Sector
Health Care
Sub-industry
Biotechnology
Headquarters
Foster City, California
Founded
1987
Added to S&P 500
2004-07-01
Index membership
S&P 500, NASDAQ-100

What you'll see in your GILD model

  • 10 years of audited historical financials for Gilead Sciences, sourced directly from the SEC's EDGAR XBRL filings (10-K and 10-Q).
  • Triangulated Wall Street consensus for GILD's forward revenue, EBITDA, and EPS across Yahoo Finance, NASDAQ, and StockAnalysis with cross-source dispersion (σ).
  • AI Event Factors: top-10 news/social themes for GILD with probability sliders and live EPS impact.
  • Sensitivity tables and Excel export for every assumption.

About Gilead Sciences

Gilead Sciences (NYSE/NASDAQ: GILD) was founded in 1987 and is headquartered in Foster City, California. The company operates in the Health Care sector (Biotechnology sub-industry) and is a constituent of the S&P 500 and NASDAQ-100. Our projection model builds a clean discounted-cash-flow view of Gilead Sciences in roughly five seconds and lets you adjust every assumption to test your own thesis.